POS-281 Prognostic Significance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and its Implications for the Potential Mechanisms of IV Iron Benefit in Maintenance Haemodialysis Patients

• B. Oliveira,
• F.M. Barakat,
• M. Robertson,
• I. Ford,
• C.I. Macdougall,
• D. Okonko

Affiliations

B. Oliveira

Kings College London, School of Cardiovascular Medicine & Sciences, London, United Kingdom

F.M. Barakat

Kings College London, School of Cardiovascular Medicine & Sciences, London, United Kingdom

M. Robertson

University of Glasgow, Robertson Centre for Biostatistics, Glasgow, United Kingdom

I. Ford

University of Glasgow, Robertson Centre for Biostatistics, Glasgow, United Kingdom

C.I. Macdougall

King's College Hospital, Department Renal Medicine, London, United Kingdom

D. Okonko

Kings College London, School of Cardiovascular Medicine & Sciences, London, United Kingdom